Herman Augustinus De Kock

This inventor holds 36 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 21 EPO patents, primarily in HCV Inhibitors. Top assignees: Tibotec Pharmaceuticals Ltd., Medivir Ab, Janssen R&d Ireland. Active years: 2007-2018.

USPTO Granted Patents = 36 (Patent Applications = 2)

% Patents Active = 16.7

CIPO Patents = 2

EPO Patents = 21 (Patent Applications = 5)

Average Co-Inventor Count = 6.0

ph-index = 6

Forward Citations = 76(Granted Patents)

Location History:

Wolfseind, BE (2011)
Arendock, BE (2014)
Arendonk, BE (2007 - 2018)

Company Filing History:

19 out of 67

Tibotec Pharmaceuticals Ltd.

Janssen Sciences Ireland Uc

patents

5. 1 out of 161

Janssen Pharmaceuticals, Inc.

Tibotec Pharmaceuticals Ltd. Co

patent

where one patent can have more than one assignee

Years Active: 2007-2018

Loading Chart...

Areas of Expertise:

Macrocyclic Inhibitors

HCV

HIV Protease Inhibitors

Sulfonamide Compounds

Amorphous Salt

Pharmacokinetics

Benzimidazole

Aminophenylsulfonamide

Benzothiazole

Hexahydrofuro

Broad Spectrum

Cyanophenyl

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9856265 - Macrocyclic inhibitors of hepatitis C virus (2018-01-02),

2. 9623022 - Macrocyclic inhibitors of hepatitis C virus (2017-04-18),

3. 9365582 - Macrocyclic inhibitors of hepatitis C virus (2016-06-14),

4. 9353103 - Macrocyclic inhibitors of hepatitis C virus (2016-05-31),

5. 9321758 - Amorphous salt of a macrocyclic inhibitor of HCV (2016-04-26),

6. 9040562 - Macrocyclic inhibitors of hepatitis C virus (2015-05-26),

7. 8754116 - Macrocyclic inhibitors of hepatitis C virus (2014-06-17),

8. 8754106 - Macrocyclic inhibitors of hepatitis C virus (2014-06-17),

9. 8754105 - Macrocyclic inhibitors of hepatitis C virus (2014-06-17),

10. 8741926 - Macrocyclic inhibitors of hepatitis C virus (2014-06-03),

11. 8637663 - Macrocyclic inhibitors of hepatitis C virus (2014-01-28),

12. 8580981 - Process for the preparation of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate (2013-11-12),

13. 8557854 - Use of a sulfonamide compound for improving the pharmacokinetics of a drug (2013-10-15),

14. 8349869 - Macrocylic inhibitors of hepatitis C virus (2013-01-08),

15. 8318779 - Lysine related derivatives as HIV aspartyl protease inhibitors (2012-11-27),

Title: The Innovative Mind of Herman Augustinus De Kock

Introduction: Herman Augustinus De Kock, a pioneering inventor hailing from Arendonk, Belgium, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Herman Augustinus De Kock's latest patents showcase his ingenuity in developing cutting-edge solutions for various industries, including robotics, renewable energy, and healthcare.

Career Highlights: Throughout his illustrious career, Herman Augustinus De Kock has consistently pushed the boundaries of innovation, earning recognition for his revolutionary inventions that have transformed the way we live and work.

Collaborations: Herman Augustinus De Kock has collaborated with leading research institutions, universities, and tech companies to bring his visionary ideas to life, fostering a culture of innovation and excellence in the industry.

Conclusion: Herman Augustinus De Kock's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.